This list is based on the watchlists of people on Stock Events who follow CKMTF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Show more...
FAQ
What is Carmat SA stock price today?▼
The current price of CKMTF is $12.75 USD — it has decreased by -50.96% in the past 24 hours. Watch Carmat SA stock price performance more closely on the chart.
What is Carmat SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Carmat SA stocks are traded under the ticker CKMTF.
What is Carmat SA revenue for the last year?▼
Carmat SA revenue for the last year amounts to 3.08M USD.
What is Carmat SA net income for the last year?▼
CKMTF net income for the last year is -59.19M USD.
How many employees does Carmat SA have?▼
As of April 04, 2026, the company has 182 employees.
In which sector is Carmat SA located?▼
Carmat SA operates in the Manufacturing sector.
When did Carmat SA complete a stock split?▼
Carmat SA has not had any recent stock splits.
Where is Carmat SA headquartered?▼
Carmat SA is headquartered in Velizy Villacoublay, FR.